Suchergebnisse - "Burchert, Andreas"

PubPharm (174)

1

No impact of time from diagnosis to treatment on survival in newly diagnosed AML treated with venetoclax-based regimens

enthalten in: ResearchSquare.com | 2024

von Baden, D. | Zukunft, S. | Hernández, G. | +36

2

No impact of time from diagnosis to treatment on survival in newly diagnosed AML treated with venetoclax-based regimens

enthalten in: ResearchSquare.com | 2024

von Baden, D. | Zukunft, S. | Hernández, G. | +36

3

Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens

enthalten in: Haematologica | 2024

von Baden, D. | Zukunft, S. | Hernandez, G. | +36

4

Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis-associated adhesion of ovarian cancer cells

enthalten in: Clinical and translational medicine | 2024

von Neuhaus, F. | Lieber, S. | Shinkevich, V. | +17

5

Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence

enthalten in: NPJ digital medicine | 2024

von Eckardt, J. | Hahn, W. | Röllig, C. | +16

6

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia : Final Analysis and Novel Prognostic Factors for Treatment-Free Remission

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Mahon, F. | Pfirrmann, M. | Dulucq, S. | +65

7

The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib

enthalten in: Leukemia | 2024

von Machova Polakova, K. | Albeer, A. | Polivkova, V. | +34

8

Prospective Assessment of Treatment-Induced Liver Injury as a Cause of Diffuse Pathologic Hepatic Enhancement in Contrast-Enhanced Ultrasound

enthalten in: Ultrasound in medicine & biology | 2024

von Wiemers, H. | Burchert, A. | Michel, C. | +5

9

Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation

enthalten in: Leukemia | 2024

von Huuhtanen, J. | Adnan-Awad, S. | Theodoropoulos, J. | +18

10

Serum proteomics hint at an early T-cell response and modulation of SARS-CoV-2-related pathogenic pathways in COVID-19-ARDS treated with Ruxolitinib

Erschienen: Marburg, Philipps-Universität Marburg, 2024

von Völkel, S. | Tarawneh, T. | Sacher, L. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]